T1	p 51 69	premature monkey :
T2	p 206 234	monkey ( Macaca nemestrina )
T3	p 1027 1034	infants
T4	p 1040 1061	dexamethasone-treated
T5	i 81 106	antenatal dexamethasone .
T6	i 137 171	antenatal glucocorticoid treatment
T7	i 286 290	dams
T8	i 300 330	dexamethasone ( 2 mg/dose ) 72
T9	i 354 372	abdominal delivery
T10	i 438 446	saline .
T11	i 458 484	dexamethasone-treated dams
T12	i 1512 1525	dexamethasone
T13	i 1623 1646	Antenatal dexamethasone
T14	o 509 534	incidence and severity of
T15	o 632 641	treatment
T16	o 707 731	volume-pressure behavior
T17	o 747 787	lungs included greater distensibility in
T18	o 792 831	infants from dexamethasone-treated dams
T19	o 925 934	stability
T20	o 950 1023	. Accelerated production of surface active material ( SAM ) phospholipids
T21	o 1097 1122	total lung phospholipid (
T22	o 1194 1228	alveolar lavage fluid phospholipid
T23	o 1303 1368	and alveolar lavage fluid disaturated phosphatidylcholine ( DPC )
T24	o 1443 1489	Incorporation of 14C-palmitate into lung lipid
T25	o 1702 1710	severity
T26	o 1823 1833	maturation
T27	o 1837 1852	fetal pulmonary